Susan M. Kanaya

2021

In 2021, Susan M. Kanaya earned a total compensation of $3.9M as Executive Vice President, Chief Financial and Administrative Officer and Secretary at ChemoCentryx, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$298,872
Option Awards$1,020,944
Salary$543,403
Stock Awards$2,068,318
Other$2,762
Total$3,934,299

Kanaya received $2.1M in stock awards, accounting for 53% of the total pay in 2021.

Kanaya also received $298.9K in non-equity incentive plan, $1M in option awards, $543.4K in salary and $2.8K in other compensation.

Rankings

In 2021, Susan M. Kanaya's compensation ranked 3,406th out of 12,415 executives tracked by ExecPay. In other words, Kanaya earned more than 72.6% of executives.

ClassificationRankingPercentile
All
3,406
out of 12,415
73rd
Division
Manufacturing
1,380
out of 5,505
75th
Major group
Chemicals And Allied Products
560
out of 2,375
76th
Industry group
Drugs
499
out of 2,096
76th
Industry
Pharmaceutical Preparations
346
out of 1,546
78th
Source: SEC filing on April 5, 2022.

Kanaya's colleagues

We found four more compensation records of executives who worked with Susan M. Kanaya at ChemoCentryx in 2021.

2021

Thomas Schall

ChemoCentryx

Chief Executive Officer

2021

Tausif Butt

ChemoCentryx

Chief Operating Officer

2021

Markus Cappel

ChemoCentryx

Chief Business Officer

2021

Rita Jain

ChemoCentryx

Chief Medical Officer

News

You may also like